1. Rehm J, Samokhvalov AV, Shield KD. Global burden of alcoholic liver diseases. J Hepatol 2013;59:160-168.
2. Blachier M, Leleu H, Peck-Radosavljevic M, Valla DC, Roudot-Thoraval F. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol 2013;58:593-608.
6. Horie Y, Ebinuma H, Kikuchi M, Nakamoto N, Kanai T. Current status of alcoholic liver diseases in Japan. Kanzo 2015;56:366-368.
7. Horie Y, Kikuchi M, Ebinuma H, Shiba S, Taniki N, Chu PS, et al. Current status of alcoholic hepatocellular carcinoma in Japan-nationwide survey in 2014. Kanzo 2016;57:538-547.
8. Kikuchi M, Horie Y, Ebinuma H, Taniki N, Nakamoto N, Kanai T. Alcoholic liver cirrhosis and significant risk factors for the development of alcohol-related hepatocellular carcinoma--Japan, 2012. Nihon Arukoru Yakubutsu Igakkai Zasshi 2015;50:222-234.
9. Willenbring ML, Olson DH. A randomized trial of integrated outpatient treatment for medically ill alcoholic men. Arch Intern Med 1999;159:1946-1952.
12. Kikuchi M, Sugihara M, Ishihara R, Oguro S, Sato Y, Mizuno Y, et al. Interdisciplinary approach (TAPPY: Tokyo Medical Center alcoholic program with physicians) for alcohol use disorders and alcoholism. Alcohol and Biomedical Research 2019;38:52-53.
13. Saunders SM, Zygowicz KM, D’Angelo BR. Person-related and treatment-related barriers to alcohol treatment. J Subst Abuse Treat 2006;30:261-270.
14. Kohn R, Sexena S, Levav I, Saraceno B. The treatment gap in mental health care. Bull World Health Organ 2004;82:858-866.
16. Kitamura K, Fetters MD, Takenaka H, Sato J, Ban N. Recognition of alcohol-related problems by primary care physicians in Japan. Jpn J Prim Care 2001;24:104-110.
17. Ban S, Kitamura K, Ichihara S, Yanagida K, Fukuoka H, Tasaka Y, et al. Primary care multicenter collaborative study on alcohol-related disorders. Japan Medical Journal 1999;3945:37-43.
18. Kikuchi M, Mizuno Y, Sato Y, Sugihara M, Horie Y. Problems in alcohol medical care and efforts at my hospital. HEP 2017;44:677-682.
19. National Institute for Health and Care Excellence (NICE). Alcoholuse disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence. London: NICE; 2011.
22. Addolorato G, Leggio L, Ferrulli A, Cardone S, Vonghia L, Mirijello A, et al. Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study. Lancet 2007;370:1915-1922.
25. Borowsky SA, Strome S, Lott E. Continued heavy drinking and survival in alcoholic cirrhotics. Gastroenterology 1981;80:1405-1409.
27. Luca A, García-Pagán JC, Bosch J, Feu F, Caballería J, Groszmann RJ, et al. Effects of ethanol consumption on hepatic hemodynamics in patients with alcoholic cirrhosis. Gastroenterology 1997;112:1284-1289.
28. Larimer ME, Palmer RS, Marlatt GA. Relapse prevention. An overview of Marlatt’s cognitive-behavioral model. Alcohol Res Health 1999;23:151-160.
32. Dieperink E, Ho SB, Heit S, Durfee JM, Thuras P, Willenbring ML. Significant reductions in drinking following brief alcohol treatment provided in a hepatitis C clinic. Psychosomatics 2010;51:149-156.
33. Weinrieb RM, Van Horn DH, Lynch KG, Lucey MR. A randomized, controlled study of treatment for alcohol dependence in patients awaiting liver transplantation. Liver Transpl 2011;17:539-547.
34. Naruse N. Skills required of supporters. In: Higuchi S, ed. New guidelines for diagnosis and treatment of alcohol/drug use disorders. Tokyo: Shinko Igaku Shupan; 2018. p. 34.
35. Yokoyama K, Ishii H. Relationship between prognosis of alcoholism and complication of diabetes. Igakunoayumi 1991;156:681.
36. Higuchi S, Saito T. Reduction in alcohol consumption: therapeutic goal in alcohol dependence treatment. Nihon Arukoru Yakubutsu Igakkai Zasshi 2013;48:17-31.